The Prognostic Effect of <i>KRAS</i> Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study

The Prognostic Effect of <i>KRAS</i> Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study

Background: due to emerging therapeutics targeting <i>KRAS</i> G12C and previous reports with conflicting results regarding the prognostic impact of <i>KRAS</i> and <i>KRAS</i> G12C in non-small cell lung cancer (NSCLC), we aimed to investigate the frequency of &l...

Full description

Bibliographic Details
Main Authors:	Sissel Gyrid Freim Wahl, Hong Yan Dai, Elisabeth Fritzke Emdal, Thomas Berg, Tarje Onsøien Halvorsen, Anine Larsen Ottestad, Marius Lund-Iversen, Odd Terje Brustugun, Dagny Førde, Erna-Elise Paulsen, Tom Donnem, Sigve Andersen, Bjørn Henning Grønberg, Elin Richardsen
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Cancers
Subjects:	non-small cell lung cancer cohort study survival signalling pathway <i>KRAS</i> <i>KRAS</i> G12C
Online Access:	https://www.mdpi.com/2072-6694/13/17/4294

Similar Items

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer
by: Anine Larsen Ottestad, et al.
Published: (2023-07-01)

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer
by: Anine Larsen Ottestad, et al.
Published: (2023-07-01)

Concordance of KRAS mutation status between luminal and peripheral regions of primary colorectal cancer. A laser-capture microdissection-based study
by: Magdalena Lewandowska, et al.
Published: (2016-05-01)

A Critical Review of the Prognostic and Predictive Implications of <i>KRAS</i> and <i>STK11</i> Mutations and Co-Mutations in Metastatic Non-Small Lung Cancer
by: Peter Manolakos, et al.
Published: (2023-06-01)

Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene—A Literature Review and Single-Center Experience
by: Anna K. Rekowska, et al.
Published: (2024-01-01)

Prognostic Value of <i>KRAS</i> Mutations in Colorectal Cancer Patients
by: Asimina Koulouridi, et al.
Published: (2022-07-01)

Therapeutic Targets of KRAS in Colorectal Cancer
by: Shafia Rahman, et al.
Published: (2021-12-01)

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers
by: Elona Cekani, et al.
Published: (2022-08-01)

<i>KRAS</i> Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer
by: Ella A. Eklund, et al.
Published: (2022-04-01)

Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less <i>KRAS</i> and More <i>EGFR</i> Mutations Compared to Advanced Adenocarcinomas
by: Jennie Petterson, et al.
Published: (2024-03-01)

Efficacy of Immunotherapy in Second-Line Treatment of <i>KRAS</i>-Mutated Patients with Non-Small-Cell Lung Cancer—Data from Daily Practice
by: Magdalena Knetki-Wróblewska, et al.
Published: (2022-12-01)

Prognostic Role of <i>KRAS G12C</i> Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Durgesh Wankhede, et al.
Published: (2023-09-01)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
by: Sissel Gyrid Freim Wahl, et al.
Published: (2021-05-01)

Direct Targeting <i>KRAS</i> Mutation in Non-Small Cell Lung Cancer: Focus on Resistance
by: Damien Reita, et al.
Published: (2022-03-01)

<i>KRAS</i>-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
by: Serena Ceddia, et al.
Published: (2022-08-01)

Targeting <i>KRAS</i> in Cancer: Promising Therapeutic Strategies
by: Lisa Maria Mustachio, et al.
Published: (2021-03-01)

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy
by: Pinto Rosamaria, et al.
Published: (2019-08-01)

Crucial Role of Oncogenic <i>KRAS</i> Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications
by: Anabela Ferreira, et al.
Published: (2022-07-01)

MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS
by: Xinquan Wu, et al.
Published: (2017-12-01)

Target-Specific Nanoparticle Polyplex Down-Regulates Mutant <i>Kras</i> to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression
by: Jill P. Smith, et al.
Published: (2023-01-01)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
by: Enrico Gurreri, et al.
Published: (2023-05-01)

Daily Practice Assessment of <i>KRAS</i> Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
by: Christophe Bontoux, et al.
Published: (2022-03-01)

Eicosapentaenoic Acid Inhibits <i>KRAS</i> Mutant Pancreatic Cancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation
by: Ching-Feng Chiu, et al.
Published: (2021-03-01)

Active Compound of <i>Pharbitis</i> Semen (<i>Pharbitis nil</i> Seeds) Suppressed KRAS-Driven Colorectal Cancer and Restored Muscle Cell Function during Cancer Progression
by: Jisu Song, et al.
Published: (2020-06-01)

Molecular Genetic Investigation of Digital Melanoma in Dogs
by: David Conrad, et al.
Published: (2022-01-01)

Molecular Divergence upon <i>EGFR</i>-TKI Resistance Could Be Dependent on the Exon Location of the Original <i>EGFR</i>-Sensitizing Mutation
by: Roberto Serna-Blasco, et al.
Published: (2022-09-01)

CT-Based Radiomics to Predict <i>KRAS</i> Mutation in CRC Patients Using a Machine Learning Algorithm: A Retrospective Study
by: Jacobo Porto-Álvarez, et al.
Published: (2023-07-01)

Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors
by: Leonie Gebauer, et al.
Published: (2021-10-01)

Clinicopathological Characteristics and Mutational Landscape of <i>APC</i>, <i>HOXB13,</i> and <i>KRAS</i> among Rwandan Patients with Colorectal Cancer
by: Felix Manirakiza, et al.
Published: (2023-05-01)

Noncoding RNA Profile in Reovirus Treated <i>KRAS</i>-Mutated Colorectal Cancer Patients
by: Rafael Saperstein, et al.
Published: (2023-10-01)

Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal Cancer
by: David Shifteh, et al.
Published: (2020-07-01)

<i>KRAS</i> Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia
by: Hidayati Husainy Hasbullah, et al.
Published: (2023-02-01)

Association of <i>KRAS</i> G12C Status with Age at Onset of Metastatic Colorectal Cancer
by: Marcelo Sunagua Aruquipa, et al.
Published: (2024-02-01)

The Inhibition of Wnt Restrain KRAS<sup>G12V</sup>-Driven Metastasis in Non-Small-Cell Lung Cancer
by: Pei-Shan Hung, et al.
Published: (2020-03-01)

<i>KRAS</i> and <i>BRAF</i> Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort
by: Paul Habashy, et al.
Published: (2023-12-01)

Evaluation of <i>RAS</i> Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
by: Elena Lastraioli, et al.
Published: (2023-05-01)

The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program–Results of a Survey on Daily Practice Patterns for Patients with mCRC
by: Gerald Prager, et al.
Published: (2021-06-01)

Ponorni kontaktni kras Zrenjskega ravnika, Istra, Hrvaška
by: Uroš Stepišnik
Published: (2022-12-01)

KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
by: Margherita Vannucchi, et al.
Published: (2023-03-01)

<i>KRAS, NRAS, BRAF, HER2</i> and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
by: Aleksandr S. Martianov, et al.
Published: (2023-03-01)